Association of patient and disease characteristics with outcomes of regorafenib in patients with metastatic colorectal cancer.

被引：0
|
作者：
Hsieh, Ronan Wenhan
Lee, Matthew
Johnson, Devin
Zhang, Chenxin
Moon, Jee-Young
Hsu, Dennis
Acuna-Villaorduna, Ana
Kuang, Chaoyuan
机构：
[1] Univ Pittsbugh, Med Ctr, Pittsburgh, PA USA
[2] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
[4] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
135
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [41] The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice
    Yoon, Sang Eun
    Lee, Su Jin
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Young Suk
    Kim, Seung Tae
    ONCOTARGETS AND THERAPY, 2019, 12 : 225 - 231
  • [42] Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib
    Liu, Yingmiao
    Lyu, Jing
    Burdett, Kirsten Bell
    Sibley, Alexander B.
    Hatch, Ace J.
    Starr, Mark D.
    Brady, John C.
    Hammond, Kelli
    Marmorino, Federica
    Rossini, Daniele
    Goldberg, Richard M.
    Falcone, Alfredo
    Cremolini, Chiara
    Owzar, Kouros
    Ivanova, Anastasia
    Moore, Dominic T.
    Lee, Michael S.
    Sanoff, Hanna K.
    Innocenti, Federico
    Nixon, Andrew B.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2146 - 2154
  • [43] Trifluridin/tipiracil and regorafenib sequencing in Slovenian patients with metastatic colorectal cancer
    Mesti, T.
    Leskovsek, K.
    Boshkoska, B. Mileva
    Boskoski, P.
    Ocvirk, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S176 - S176
  • [44] Investigation of Regorafenib-induced Hypothyroidism in Patients with Metastatic Colorectal Cancer
    Sugita, Kazuo
    Kawakami, Kazuyoshi
    Yokokawa, Takashi
    Mae, Yutaro
    Toya, Wataru
    Hagino, Akane
    Suzuki, Kenichi
    Suenaga, Mitsukuni
    Mizunuma, Nobuyuki
    Yamaguchi, Toshiharu
    Hama, Toshihiro
    ANTICANCER RESEARCH, 2015, 35 (07) : 4059 - 4062
  • [45] Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
    Ricci, Vincenzo
    Granetto, Cristina
    Falletta, Antonella
    Paccagnella, Matteo
    Abbona, Andrea
    Fea, Elena
    Fabozzi, Teresa
    Lo Nigro, Cristiana
    Merlano, Marco Carlo
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (03) : 301 - 310
  • [46] The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib
    Yekeduz, Emre
    Aktas, Elif Gizem
    Koksoy, Elif Berna
    Dogan, Neslihan
    Urun, Yuksel
    Utkan, Gungor
    FUTURE ONCOLOGY, 2022, 18 (09) : 1067 - 1076
  • [47] Clinical outcomes in patients age 40 or younger at diagnosis of synchonous metastatic colorectal cancer.
    Lowery, M. A.
    Gallagher, D. J.
    Kemeny, N. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [48] Comparison of treatment outcomes of regorafenib for patients with metastatic colorectal cancer by era: A propensity-score matched analysis
    Ogata, T.
    Harada, K.
    Kawakami, T.
    Hu, Q.
    Kadowaki, S.
    Taniguchi, H.
    Muro, K.
    Yamamura, T.
    Kawamoto, Y.
    Komatsu, Y.
    Fushiki, K.
    Oshima, K.
    Nakanishi, R.
    Ando, K.
    Nambara, S.
    Masuishi, T.
    Yamazaki, K.
    Oki, E.
    Yuki, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S86 - S87
  • [49] Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study
    Yekeduz, Emre
    Ozbay, Mehmet Fatih
    Caglayan, Dilek
    Yildirim, Atila
    Erol, Cihan
    Yildirim, Hasan Cagri
    Tunc, Sezai
    Ozyurt, Neslihan
    Ozdemir, Feyyaz
    Sendur, Mehmet Ali Nahit
    Isikdogan, Abdurrahman
    Kilickap, Saadettin
    Urun, Yuksel
    Yalcin, Suayib
    Artac, Mehmet
    Coskun, Hasan Senol
    Utkan, Gungor
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1973 - 1979
  • [50] Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial
    Karthaus, M.
    Schwenke, S.
    Seidel, H.
    Beckmann, G.
    Reischl, J.
    Vonk, R.
    Lenz, H. -J
    Tebernero, J.
    Siena, S.
    Grothey, A.
    van Cutsem, E.
    Jeffers, M.
    Wagner, A.
    Laurent, D.
    Kobina, S.
    Rutstein, M.
    Guinney, J.
    Tejpar, S.
    Oncology Research and Treatment, 2015, 38 : 57 - 58
12345